Effect of activated platelets on expression of cytokines in peripheral blood mononuclear cells - Potential role of prostaglandin E2

Thrombosis and Haemostasis

Volumn 92, Issue 6, 2004, Pages 1358-1367

  Wæhre, Torgun ^a   Damås, Jan Kristian ^a   Yndestad, Arne ^a   Taskén, Kjetil ^b   Pedersen, Turid M ^a   Smith, Camilla ^a   Halvorsen, Bente ^a   Frøland, Stig S ^a   Solum, Nils O ^a   Aukrust, Pål ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Inflammation; Interleukin 6; Mononuclear cells; Platelets; Prostaglandin E2

Indexed keywords

BROMINE DERIVATIVE; CHEMOKINE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PROSTAGLANDIN E2; PROTEIN INHIBITOR;

ADULT; ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; MALE; MOLECULAR MECHANICS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; SUPERNATANT; THROMBOCYTE ACTIVATION; THROMBOCYTE RICH PLASMA;

ADULT; CELLS, CULTURED; CYTOKINES; DINOPROSTONE; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; IMMUNOENZYME TECHNIQUES; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLATELET ACTIVATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 10444227277     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-03-0146     Document Type: Article

References (27)

1. Klinger MHF. Platelets and inflammation. Anat Embryol 1997; 196: 1-11.
2. Clemetson KJ, Clemetson JM, Proudfoot AEI, et al. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors in human platelets. Blood 2000; 96: 4046-54.
3. Aukrust P, Waehre T, Damas JK, et al. Inflammatory role of platelets in acute coronary syndromes. Heart 2001; 86: 605-6.
4. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
5. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med 2002; 30: S513-S517.
6. Weyrich AS, McIntyre TM, McEver RP, et al. Monocyte tethering by P-selektin regulates monocyte chemotactic protein-1 and tumor necrosis factor-alpha secretion. Signal integration and NF-kappa B translocation. J Clin Invest 1995; 95: 2297-303.
7. Weyrich AS, Elstad MR, McEver RP, et al. Activated patelets signal chemokine ynthesis by human monocytes. J Clin Invest 1996; 97: 1525-34.
8. Taskén K, Hansson V, Aukrust P, et al. Protein kinase type 1 as a potential target for therapeutic intervention. Drugs News Perspect 2000; 13: 12-8.
9. Holme PA, Muller F, Solum NO, et al. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection. FASEB J 1998; 12: 79-90.
10. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis. J Cell Biol 2001; 154: 485-90.
11. Yndestad A, Damås JK, Eiken HG, et al. Increased gene expression of tumor necrosis factor super family ligand in peripheral mononuclear cells during chronic heart failure. Cardiovasc Res 2002; 54: 175-82.
12. Yndestad A, Holm AM, Muller F, et al. Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure. Cardiovasc Res 2003; 60: 141-6.
13. Naldini A, Pucci A, Carney DH, et al. Thrombin enhancement of interleukin-1 expression in mononuclear cells: involvement of proteinase-activated receptor-1. Cytokine 2002; 20: 191-9.
14. Iwahashi H, Takeshita A, Hanazawa S. Prostaglandin E2 stimulates AP-1-mediated CD14 expression in mouse macrophages via cyclic AMP-dependent protein kinase A. J Immunol 2000; 164: 5403-8.
15. Smith JB, Willis AL. Formation and release of prostaglandins by platelets in response to thrombin. Br J Pharmacol 1970; 40: 545P.
16. Tsuboi K, Sugimoto Y, Ichikawa A. Prostanoid receptor subtypes. Prostaglandins Other Lipid Mediat 2002; 68-9: 535-6.
17. Moore KL, de Waal Malefyt R, Coffman RL, et al. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-65.
18. Holm AM, Aukrust P, Aandahl EM, et al. Impaired secretion of interleukin-10 by T cells from patients with common variable immunodeficiency - involvement of protein kinase A type I. J Immunol 2003; 170: 5772-7.
19. Mertz PM, DeWitt DL, Stetler-Stevenson WG, et al. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J Biol Chem 1994; 269: 21322-9.
20. Rajeevan MS, Vernon SD, Taysavang N, et al. Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR. J Mol Diagn 2001; 3: 26-31.
21. Neumann F-J, Marx N, Gawas M, et al. Induction of cytokine expression i leukocytes by binding og thrombin-stimulated platelets. Circulation 1997; 95: 2387-94.
22. Holm T, Damås JK, Holven K, et al. CXC-chemokines in coronary artery disease: possible role of interactions between oxidized low-density lipoprotein, platelets and peripheral blood mononuclear cells. J Thromb Haemost 2003; 1: 257-62.
23. Papandicolaou DA. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998; 128: 127-37.
24. Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997; 349: 490-5.
25. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol 2001; 2: 108-15.
26. Damås JK, Gullestad L, Ueland T, et al. CXC-chemokines, a new group of cytokines in cardiac heart failure- possible role of platelets and monocytes. Cardiovasc Res 2000; 45: 428-36.
27. Kassis S, Lee JC, Hanna N. Effects of prostaglandins and cAMP levels on monocyte IL-1 production. Agents Actions 1989; 27: 274-6.